SMAD5 and cardiac hypertrophy: Infusion of Ang II for 2 weeks in mice induces the phosphorylation of Smad1 and Smad5 in the carboxyl-terminal, leading to cardiac hypertrophy, which is inhibited by BMPR2 inhibitor, LDN193189 [107].